Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
287
-
Total 13F shares, excl. options
-
141M
-
Shares change
-
-520K
-
Total reported value, excl. options
-
$2.43B
-
Value change
-
-$10.1M
-
Put/Call ratio
-
1.05
-
Number of buys
-
120
-
Number of sells
-
-142
-
Price
-
$17.20
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q3 2019
367 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q3 2019.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 287 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 141M shares
.
Largest 10 shareholders include GLENVIEW CAPITAL MANAGEMENT, LLC (27.4M shares), PAULSON & CO. INC. (13.2M shares), BAUPOST GROUP LLC/MA (9.43M shares), Adelphi Capital LLP (8.99M shares), VANGUARD GROUP INC (6.15M shares), MACQUARIE GROUP LTD (5.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.16M shares), BANK OF AMERICA CORP /DE/ (4.05M shares), NORTHERN TRUST CORP (3.92M shares), and Mondrian Investment Partners LTD (3.64M shares).
This table shows the top 287 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.